KATHRYN-CARRIE WELLS: Open Payments
NPI 1689162349 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$982 in 44 payments from 10 companies in 2025. Trend: 2023 $2,174 · 2024 $2,015 · 2025 $982
Food & beverage: $882Education: $100
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 14 | $266 |
| Novartis Pharmaceuticals Corporation | 5 | $182 |
| ABBVIE INC. | 8 | $159 |
| Janssen Biotech, Inc. | 5 | $156 |
| PFIZER INC. | 7 | $106 |
| Amgen Inc. | 1 | $30 |
| GlaxoSmithKline, LLC. | 1 | $23 |
| GENZYME CORPORATION | 1 | $23 |
| Alnylam Pharmaceuticals Inc. | 1 | $21 |
| Organon LLC | 1 | $16 |
Products named: Bimzelx, COSENTYX, TREMFYA, XELJANZ, RINVOQ, SKYRIZI, OTEZLA, BENLYSTA.
Industry payments across KY — which companies pay providers there.
